Research ExplorerScientific StaffFelix Klingler Publications

Dr. ID: 5310176

Felix Klingler

graph of relations
Affiliations
ORCID: 0000-0003-0861-1052
1 - 5 out of 5Page size: 50

Publications

  1. 2023

  2. Regulation of coagulation activation in newly diagnosed AML by the heme enzyme myeloperoxidase

    Langer, F., Quick, H., Beitzen-Heineke, A., Janjetovic, S., Mäder, J., Lehr, C., Bokemeyer, C., Kuta, P., Renné, T., Fiedler, W., Beckmann, L., Klingler, F. & Rolling, C. C., 09.2023, In: THROMB RES. 229, p. 155-163 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 2022

  4. Inhibition of protein disulfide isomerase with PACMA-31 regulates monocyte tissue factor through transcriptional and posttranscriptional mechanisms

    Beckmann, L., Mäder, J., Voigtlaender, M., Klingler, F., Schulenkorf, A., Lehr, C., Regenhardt, J., Bokemeyer, C., Ruf, W., Rolling, C. & Langer, F., 12.2022, In: THROMB RES. 220, p. 48-59 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Retrospective analysis of three induction chemotherapy regimens in acute myeloid leukemia including CPX-351, cytarabine/daunorubicin with and without the addition of cladribine

    Klingler, F., Alsdorf, W. H., Ghandili, S., Wolschke, C., Brauneck, F., Bokemeyer, C., Fiedler, W., Modemann, F. & Karagiannis, P., 11.2022, In: LEUKEMIA LYMPHOMA. 63, 11, p. 2645-2651 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. 2021

  7. Bacitracin and Rutin Regulate Tissue Factor Production in Inflammatory Monocytes and Acute Myeloid Leukemia Blasts

    Beckmann, L., Rolling, C. C., Voigtländer, M., Mäder, J., Klingler, F., Schulenkorf, A., Lehr, C., Bokemeyer, C., Ruf, W. & Langer, F., 04.08.2021, In: CANCERS. 13, 16, p. 3941

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. 2018

  9. Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option

    Stamm, H., Klingler, F., Grossjohann, E-M., Muschhammer, J., Vettorazzi, E., Heuser, M., Mock, U., Thol, F., Vohwinkel, G., Latuske, E., Bokemeyer, C., Kischel, R., Dos Santos, C., Stienen, S., Friedrich, M., Lutteropp, M., Nagorsen, D., Wellbrock, J. & Fiedler, W., 09.2018, In: ONCOGENE. 37, 39, p. 5269-5280 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review